BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14673743)

  • 21. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
    Basile AS; Jones EA; Skolnick P
    Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of hepatic encephalopathy with Hepa-Mertz].
    Podymova SD; Bueverov AO; Nadinskaia MIu
    Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hepatic coma].
    Wysocki J
    Przegl Epidemiol; 1969; 23(1):65-70. PubMed ID: 4892723
    [No Abstract]   [Full Text] [Related]  

  • 25. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
    Romero Gómez M; Bautista JD; Grande L; Ramos Guerrero RM; Sánchez Muñoz D
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():40-8. PubMed ID: 15195533
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current aspects of hepatic oma therapy].
    San Juan F
    Hospital (Rio J); 1969 Nov; 76(5):1539-50. PubMed ID: 4907032
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of ammonia in the pathogensis of a hepatic comma].
    Díaz Rubio M; Candel Monserrate I; Portugal Alvarez J
    Rev Clin Esp; 1968 Mar; 108(5):356-62. PubMed ID: 5674474
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of severe hyperammonemia].
    Leonhardt H; Bungert HJ
    Med Klin; 1972 Aug; 67(32):1052-6. PubMed ID: 5070916
    [No Abstract]   [Full Text] [Related]  

  • 31. Newer aspects of hepatic encephalopathy.
    Mullen KD
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S17-20. PubMed ID: 15025247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia.
    Demedts M; Pillen E; De Groote J; Van de Woestijne KP
    Acta Neurol Belg; 1973; 73(5):281-8. PubMed ID: 4785018
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental hepatic coma caused by acute ischemic necrosis of the liver in pigs. Attempted prevention and treatment with cross hemodialysis].
    Opolon P; Huguet C; Hadchouel P; Morisot P; Bloch P; Gallot D; Duhurt J; Connard J; Sausse A; Stern A; Granger A; Caroli J
    Ann Med Interne (Paris); 1971; 122(8):819-32. PubMed ID: 5124358
    [No Abstract]   [Full Text] [Related]  

  • 34. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations on the impact of hepatic encephalopathy treatments in the pretransplant setting.
    Teperman LW; Peyregne VP
    Transplantation; 2010 Apr; 89(7):771-8. PubMed ID: 20110852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic liver failure.
    Losowsky MS
    Br J Hosp Med; 1979 Nov; 22(5):448, 453-5. PubMed ID: 540199
    [No Abstract]   [Full Text] [Related]  

  • 37. [What is guaranteed in the therapy of hepatic encephalopathy?].
    Plauth M; Egberts EH
    Internist (Berl); 1993 Jan; 34(1):35-42. PubMed ID: 8440573
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic failure and its management.
    Sahu H; Misra SC; Patnaik BC; Rao PS
    J Indian Med Assoc; 1981 Mar; 76(5):79-81. PubMed ID: 7264336
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Causes, clinical aspects and therapy of hepatic coma].
    Müting D
    Krankenpfl J; 1984; 22(1-2):28-30. PubMed ID: 6560122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.